Note that the content is AI-generated and might contain mistakes. Generation might take some time.
If AI keeps you waiting, feel free to play the mini-game below in the meantime!
253/LG/SE/SEP/2025/GBSL
September 18, 2025
To,
BSE Limited,
Phiroze Jeejeebhoy Towers,
Dalal Street, Fort, Mumbai – 400 001
Scrip Code: 509079
To,
National Stock Exchange of India Limited,
Exchange Plaza, Bandra Kurla Complex,
Bandra (E), Mumbai – 400 051
Scrip Symbol : GUFICBIO
Sub.:
Intimation of Schedule of Analyst / Institutional Investor Meeting
Dear Sir/Madam,
Pursuant to the provisions of Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, please find below the details of meeting with the
Analyst/ Institutional Investor:
Date
Type of Meeting
Analyst/ Investor/ Event
Place
23rd September,
2025
One‐on‐One and
Group (In person)
DAM Capital’s Pharma & Healthcare
Conference
Mumbai
The schedule of the aforementioned meeting is subject to change and the change may occur due to
exigencies on the part of Investor / Company. We hereby confirm that the discussion during the
meeting will be based on already published information and no Unpublished Price Sensitive
Information is proposed to be discussed in this meeting.
Kindly take the same on your records.
Thanking You,
For Gufic Biosciences Limited
Ami Shah
Company Secretary & Compliance Officer
Membership No. A39579
